Authors: zur Stadt, U Harms, DO Schluter, S Schrappe, M Goebel, U Spaar, H Janka, G Kabisch, H

Citation: U. Zur Stadt et al., MRD at the end of induction therapy in childhood acute lymphoblastic leukemia: outcome prediction strongly depends on the therapeutic regimen, LEUKEMIA, 15(2), 2001, pp. 283-285

Authors: Clementi, R zur Stadt, U Savoldi, G Varotto, S Conter, V De Fusco, C Notarangelo, LD Schneider, M Klersy, C Janka, G Danesino, C Arico, M

Citation: R. Clementi et al., Six novel mutations in the PRF1 gene in children with haemophagocytic lymphohistiocytosis, J MED GENET, 38(9), 2001, pp. 643-646

Authors: zur Stadt, U Harms, DO Schluter, S Jorch, N Spaar, HJ Nurnberger, W Volpel, S Gutjahr, P Schrappe, M Janka, G Kabisch, H

Citation: U. Zur Stadt et al., Minimal residual disease analysis in acute lymphoblastic leukemia of childhood after an induction therapy without asparaginase, KLIN PADIAT, 212(4), 2000, pp. 169-173

Authors: Cario, G zur Stadt, U Reiter, A Welte, K Sykora, KW

Citation: G. Cario et al., Variant translocations in sporadic Burkitt's lymphoma detected in fresh tumour material: analysis of three cases, BR J HAEM, 110(3), 2000, pp. 537-546

Authors: Strahm, B Rittweiler, K Duffner, U Brandau, O Orlowska-Volk, M Karajannis, MA zur Stadt, U Tiemann, M Reiter, A Brandis, M Meindl, A Niemeyer, CM

Citation: B. Strahm et al., Recurrent B-cell non-Hodgkin's lymphoma in two brothers with X-linked lymphoproliferative disease without evidence for Epstein-Barr virus infection, BR J HAEM, 108(2), 2000, pp. 377-382